Braeburn / Camurus
Braeburn / Camurus is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Braeburn / Camurus products.
Drugs from Braeburn / Camurus supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Brixadi | buprenorphine ER | Other specialty | Opioid use disorder — OUT OF SCOPE (DEA Schedule III; PlatformCo does not handle controlled substances. Fatima's DEA-registered entity may pursue separately.) |
How NPP access to Braeburn / Camurus products works
Reserve Meds sources Braeburn / Camurus products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Braeburn / Camurus
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Braeburn / Camurus.